Rheumazentrum Ruhrgebiet

EFFICACY OF UST IN ACTIVE PSA IS INDEPENDENT FROM CONCOMITANT MTX USE, EVEN IN PATIENTS WITH MORE SEVERE SKIN PSORIASIS: SUBGROUP ANALYSIS FROM A RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL (2022) Koehm M, Rossmanith T, Foldenauer AC, Kellner H, Kiltz U, Rech J, Burmester GR, et al. Conference contribution COMPARISON OF PATIENTS WITH AXIAL PSA AND PATIENTS WITH AXSPA AND CONCOMITANT PSORIASIS (2022) Regierer A, Weiss A, Baraliakos X, Behrens F, Poddubnyy D, Schett G, Lorenz HM, et al. Conference contribution QUANTITATIVE ANALYSIS BY SODIUM AND PROTON BASED 3-TESLA MR IMAGING OF THE ACHILLES TENDON (2022) Muller-Lutz A, Kamp B, Klein-Schmeink L, Tsiami S, Frenken M, Nagel AM, Baraliakos X, Sewerin P Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution Neither Add-on nor Withdrawal of Methotrexate Impacts Efficacy of IL12/23 Inhibition in Active PsA: Data from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial on Arthritis, Dactylitis, Enthesitis, Psoriasis, QoL and Function (2021) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Kellner H, Kiltz U, Rech J, et al. Conference contribution Implementing an automated monitoring process in a digital, longitudinal observational cohort study (2021) Lindner L, Weiss A, Reich A, Kindler S, Behrens F, Braun J, Listing J, et al. Journal article Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland (2021) Kiltz U, Buschhorn-Milberger , Albrecht K, Lakomek HJ, Lorenz HM, Rudwaleit M, Schneider M, et al. Journal article GENDER DIFFERENCES IN PSA OUTCOME PARAMETERS AND THEIR CORRELATION WITH SKIN INVOLVEMENT: A CROSS-SECTIONAL ANALYSIS OF RABBIT-SPA PATIENTS (2020) Regierer A, Weiss A, Behrens F, Feuchtenberger M, Schett G, Baraliakos X, Zink A, Strangfeld A Conference contribution IMPACT OF METHOTREXATE ON DISEASE PATTERN IN ACTIVE PSORIATIC ARTHRITIS PATIENTS ELIGIBLE FOR A RANDOMIZED CLINICAL TRIAL WITH USTEKINUMAB: COMPARATIVE BASELINE DATA FROM MULTICENTRE INVESTIGATOR-INITIATED MUST TRIAL (2020) Rossmanith T, Koehm M, Kiltz U, Rech J, Burmester GR, Kellner H, Bulczak-Schadendorf A, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES (2019) Schett G, Baraliakos X, Van Den Bosch F, Deodhar A, Gensler LS, Ostergaard M, Agawane S, et al. Conference contribution